Can-Fite BioPharma
- Country
- 🇮🇱Israel
- Ownership
- Public
- Established
- 1994-01-01
- Employees
- 5
- Market Cap
- $12.2M
- Website
- http://www.canfite.com
- Introduction
Can-Fite BioPharma Ltd. is a biopharmaceutical company, which engages in the development of drugs for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. Its product pipeline include Piclidenoson, Namodenoson, and CF602. The company was founded by Pnina Fishman and Ilan Cohn on September 11, 1994 and is headquartered in Petach-...
A Phase 3 Study in Moderate-to-Severe Plaque Psoriasis With Piclidenoson to Study Safety and Efficacy
- First Posted Date
- 2024-10-16
- Last Posted Date
- 2024-10-16
- Lead Sponsor
- Can-Fite BioPharma
- Target Recruit Count
- 705
- Registration Number
- NCT06643260
Namodenoson Treatment of Advanced Pancreatic Cancer
- Conditions
- Interventions
- First Posted Date
- 2024-04-29
- Last Posted Date
- 2024-08-21
- Lead Sponsor
- Can-Fite BioPharma
- Target Recruit Count
- 20
- Registration Number
- NCT06387342
- Locations
- 🇮🇱
Rabin Medical Center Institute of Oncology, Petach Tikva, Israel
Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosis
- Conditions
- Interventions
- First Posted Date
- 2022-01-21
- Last Posted Date
- 2024-07-31
- Lead Sponsor
- Can-Fite BioPharma
- Target Recruit Count
- 471
- Registration Number
- NCT05201404
- Locations
- 🇧🇦
843 University Clinical Hospital Mostar, Mostar, Bosnia and Herzegovina
🇺🇸Site 881, Dallas, Texas, United States
🇧🇦842 University Clinical Centre Sarajevo, Sarajevo, Bosnia and Herzegovina
Namodenoson in the Treatment of Non-Alcoholic Steatohepatitis (NASH)
- Conditions
- Interventions
- First Posted Date
- 2021-01-06
- Last Posted Date
- 2024-07-31
- Lead Sponsor
- Can-Fite BioPharma
- Target Recruit Count
- 114
- Registration Number
- NCT04697810
- Locations
- 🇲🇩
911 IMSP Spitalul Clinic Republican "Timofei Mosneaga", Chisinau, Moldova, Republic of
🇧🇬933 Clinic of Gastroenterology, University Multiprofile Hosptial for Active Treatment, Sofia, Bulgaria
🇮🇱Hadassah Medical Center, Jerusalem, Israel
Piclidenoson for Treatment of COVID-19
- First Posted Date
- 2020-04-03
- Last Posted Date
- 2022-04-22
- Lead Sponsor
- Can-Fite BioPharma
- Target Recruit Count
- 6
- Registration Number
- NCT04333472
- Locations
- 🇮🇱
Hadassah Medical Center, Jerusalem, Israel
🇷🇴"Sfantul Ioan cel Nou" County Emergency Hospital Suceava, Suceava, Romania
🇮🇱Shaare Zedek Medical Center, Jerusalem, Israel
CF101 Therapy in Patients With Moderate-to-severe Plaque Psoriasis
- Conditions
- Interventions
- First Posted Date
- 2017-05-30
- Last Posted Date
- 2022-06-28
- Lead Sponsor
- Can-Fite BioPharma
- Target Recruit Count
- 528
- Registration Number
- NCT03168256
- Locations
- 🇧🇬
"MHAT"Rahila Angelova"AD, Department of Skin and Venereal Diseases, Pernik, Bulgaria
🇧🇬"Diagnostic-Consultative Centre XX - Sofia" EOOD, Sofia, Bulgaria
🇵🇱Gdańskim Centrum Zdrowia, Gdańsk, Poland
A Study of the Efficacy and Safety of CF102 in the Treatment of Non-Alcoholic Fatty Liver Disease
- First Posted Date
- 2016-10-07
- Last Posted Date
- 2020-03-17
- Lead Sponsor
- Can-Fite BioPharma
- Target Recruit Count
- 60
- Registration Number
- NCT02927314
- Locations
- 🇮🇱
Can-Fite Investigational Site #311, Petach Tikva, Israel
🇮🇱Can-Fite Investigational Site #319, Nazareth, Israel
🇮🇱Can-Fite Investigational Site #318, Jerusalem, Israel
CF101 Therapy Compared to Methotrexate Therapy for Active Rheumatoid Arthritis
- Conditions
- Interventions
- First Posted Date
- 2016-01-06
- Last Posted Date
- 2020-12-19
- Lead Sponsor
- Can-Fite BioPharma
- Target Recruit Count
- 244
- Registration Number
- NCT02647762
- Locations
- 🇷🇸
Can-Fite Investigational Site #215, Niš, Serbia
🇲🇩Can-Fite Investigational Site #583, Chisinau, Moldova, Republic of
🇷🇴Can-Fite Investigational Site #553, Bucuresti, Romania
Phase 2, Randomized, Double-Blind, Placebo-Controlled of the Efficacy and Safety of CF102 in Hepatocellular Carcinoma (HCC)
- First Posted Date
- 2014-05-01
- Last Posted Date
- 2022-10-04
- Lead Sponsor
- Can-Fite BioPharma
- Target Recruit Count
- 78
- Registration Number
- NCT02128958
- Locations
- 🇧🇬
Multiprofile Hospital for Active Treatment Central Onco Hospita, Plovdiv, Bulgaria
🇧🇬Multiprofile Hospital for Active Treatment "Tokuda Hospital Sofia" AD, Sofia, Bulgaria
🇷🇴Spitalului Clinic Judetean de Urgenta - Sectia Oncologie Medicala, Sibiu, Romania
Safety &Efficacy of CF101 to Subjects With Uveitis
- Conditions
- Interventions
- First Posted Date
- 2013-07-23
- Last Posted Date
- 2018-02-01
- Lead Sponsor
- Can-Fite BioPharma
- Registration Number
- NCT01905124
- Locations
- 🇮🇱
Bnei-Zion Medical Center, Haifa, Israel